These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 16615675)

  • 1. Chronic hydroxychloroquine use associated with QT prolongation and refractory ventricular arrhythmia.
    Chen CY; Wang FL; Lin CC
    Clin Toxicol (Phila); 2006; 44(2):173-5. PubMed ID: 16615675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular Safety of Hydroxychloroquine in US Veterans With Rheumatoid Arthritis.
    Faselis C; Zeng-Treitler Q; Cheng Y; Kerr GS; Nashel DJ; Liappis AP; Weintrob AC; Karasik PE; Arundel C; Boehm D; Heimall MS; Connell LB; Taub DD; Shao Y; Redd DF; Sheriff HM; Zhang S; Fletcher RD; Fonarow GC; Moore HJ; Ahmed A
    Arthritis Rheumatol; 2021 Sep; 73(9):1589-1600. PubMed ID: 33973403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the risk of QTc prolongation associated with hydroxychloroquine use with antidepressants in lupus patients with fibromyalgia.
    Renaldi J; Koumpouras F; Dong X
    Lupus; 2021 Oct; 30(11):1844-1848. PubMed ID: 34353174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suspected hydroxychloroquine-associated QT-interval prolongation in a patient with systemic lupus erythematosus.
    Morgan ND; Patel SV; Dvorkina O
    J Clin Rheumatol; 2013 Aug; 19(5):286-8. PubMed ID: 23872551
    [No Abstract]   [Full Text] [Related]  

  • 5. QTc interval prolongation in patients with systemic lupus erythematosus treated with hydroxychloroquine.
    Nishiyama T; Kondo Y; Tsuboi H; Noma H; Tabuchi D; Sugita T; Okamoto S; Terasaki T; Shimizu M; Honda F; Ohyama A; Kurata I; Yagishita M; Abe S; Takahashi H; Osada A; Hagiwara S; Matsumoto I; Sumida T
    Mod Rheumatol; 2021 Nov; 31(6):1107-1112. PubMed ID: 33496215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of hydroxychloroquine treatment on QT interval.
    Hooks M; Bart B; Vardeny O; Westanmo A; Adabag S
    Heart Rhythm; 2020 Nov; 17(11):1930-1935. PubMed ID: 32610165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxychloroquine in systemic lupus erythematosus (SLE).
    Ponticelli C; Moroni G
    Expert Opin Drug Saf; 2017 Mar; 16(3):411-419. PubMed ID: 27927040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simple dose-escalation regimen for hydroxychloroquine-induced hypersensitivity reaction in patients with systemic lupus erythematosus enabled treatment resumption.
    Takamasu E; Yokogawa N; Shimada K; Sugii S
    Lupus; 2019 Oct; 28(12):1473-1476. PubMed ID: 31575325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety signals for QT prolongation or Torsades de Pointes associated with azithromycin with or without chloroquine or hydroxychloroquine.
    Sarayani A; Cicali B; Henriksen CH; Brown JD
    Res Social Adm Pharm; 2021 Feb; 17(2):483-486. PubMed ID: 32327397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cumulative dose of hydroxychloroquine is associated with a decrease of resting heart rate in patients with systemic lupus erythematosus: a pilot study.
    Cairoli E; Danese N; Teliz M; Bruzzone MJ; Ferreira J; Rebella M; Cayota A
    Lupus; 2015 Oct; 24(11):1204-9. PubMed ID: 25852050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early cutaneous eruptions after oral hydroxychloroquine in a lupus erythematosus patient: A case report and review of the published work.
    Matsuda T; Ly NTM; Kambe N; Nguyen CTH; Ueda-Hayakawa I; Son Y; Okamoto H
    J Dermatol; 2018 Mar; 45(3):344-348. PubMed ID: 29239026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroxychloroquine Does Not Increase the Risk of Cardiac Arrhythmia in Common Rheumatic Diseases: A Nationwide Population-Based Cohort Study.
    Lo CH; Wei JC; Wang YH; Tsai CF; Chan KC; Li LC; Lo TH; Su CH
    Front Immunol; 2021; 12():631869. PubMed ID: 33868251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Pharmacological Mechanisms and Therapeutic Activities of Hydroxychloroquine in Rheumatic and Related Diseases.
    Hu C; Lu L; Wan JP; Wen C
    Curr Med Chem; 2017; 24(20):2241-2249. PubMed ID: 28302011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxychloroquine-induced pigmentation in patients with systemic lupus erythematosus: a case-control study.
    Jallouli M; Francès C; Piette JC; Huong du LT; Moguelet P; Factor C; Zahr N; Miyara M; Saadoun D; Mathian A; Haroche J; De Gennes C; Leroux G; Chapelon C; Wechsler B; Cacoub P; Amoura Z; Costedoat-Chalumeau N;
    JAMA Dermatol; 2013 Aug; 149(8):935-40. PubMed ID: 23824340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of hydroxychloroquine on preterm delivery and intrauterine growth restriction in pregnant women with systemic lupus erythematosus: a descriptive cohort study.
    Leroux M; Desveaux C; Parcevaux M; Julliac B; Gouyon JB; Dallay D; Pellegrin JL; Boukerrou M; Blanco P; Lazaro E
    Lupus; 2015 Nov; 24(13):1384-91. PubMed ID: 26082465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroxychloroquine desensitization, an effective method to overcome hypersensitivity-a multicenter experience.
    Tal Y; Maoz Segal R; Langevitz P; Kivity S; Darnizki Z; Agmon-Levin N
    Lupus; 2018 Apr; 27(5):703-707. PubMed ID: 28992797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydroxychloroquine in systemic lupus erythematosus and rheumatoid arthritis and its safety in pregnancy.
    Abarientos C; Sperber K; Shapiro DL; Aronow WS; Chao CP; Ash JY
    Expert Opin Drug Saf; 2011 Sep; 10(5):705-14. PubMed ID: 21417950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of long-term hydroxychloroquine on vascular events in patients with systemic lupus erythematosus: a database prospective cohort study.
    Hsu CY; Lin YS; Su YJ; Lin HF; Lin MS; Syu YJ; Cheng TT; Yu SF; Chen JF; Chen TH
    Rheumatology (Oxford); 2017 Dec; 56(12):2212-2221. PubMed ID: 29029334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [QT prolongation and torsade de pointes tachycardia during therapy with maprotiline. Differential diagnostic and therapeutic aspects].
    Lentini S; Rao ML; Schröder R; Lüderitz B; Bauriedel G
    Dtsch Med Wochenschr; 2001 Dec; 126(49):1396-400. PubMed ID: 11740632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxychloroquine cardiotoxicity in systemic lupus erythematosus: a report of 2 cases and review of the literature.
    Nord JE; Shah PK; Rinaldi RZ; Weisman MH
    Semin Arthritis Rheum; 2004 Apr; 33(5):336-51. PubMed ID: 15079764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.